Cushing's Disease
Showing 1 - 25 of >10,000
Cushing Syndrome, Cushing Disease, Ectopic ACTH Syndrome Trial run by the Crinetics Pharmaceuticals Inc. (CRN04894)
Recruiting
- Cushing Syndrome
- +2 more
-
Bethesda, MarylandNational Institutes of Health (NIH) - National Institute of Diab
Mar 27, 2023
Long-Term Follow-Up of Survivors of Pediatric Cushing Disease
Recruiting
- Cushing Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Cushing's Disease Trial run by the NINDS (Vorinostat)
Recruiting
- Cushing's Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Cushing's Disease, Pituitary Adenoma Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Acthrel)
Not yet recruiting
- Cushing's Disease
- Pituitary Adenoma
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Patients With Cushing's Syndrome
Recruiting
- Cushing's Disease
- +2 more
- Cushing's QoL (Quality of Life Questionnaire)
- +10 more
-
Basking Ridge, New Jersey
- +6 more
Jan 13, 2023
Cushing Disease Trial in Los Angeles (Seliciclib)
Active, not recruiting
- Cushing Disease
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 24, 2022
Cushing Syndrome, Fatty Liver Disease Trial (hepatic MRI)
Not yet recruiting
- Cushing Syndrome
- Fatty Liver Disease
- hepatic MRI
- (no location specified)
May 25, 2023
Cushing Disease, DVT, Pulmonary Embolism Trial in China (LMWH/Rivaroxaban, IPC)
Recruiting
- Cushing Disease
- +2 more
- LMWH/Rivaroxaban
- IPC
-
Guangzhou, Guangdong, China
- +3 more
Jul 10, 2022
Cushing Disease Trial in France (Patient group, Remission control group, Bilateral surrenalectomy control group)
Recruiting
- Cushing Disease
- Patient group
- +2 more
-
Caen, France
- +6 more
Dec 16, 2021
Pituitary Tumors and Related Hypothalmic Disorders
Recruiting
- Panhypopituitarism
- +3 more
- MRI
- Tissue specimen collection
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Novel Mediators of Lipodystrophy and Metabolic Consequences of
Completed
- Cushing's Syndrome
- Treatment of Cushing's
-
New York, New YorkColumbia University Neuroendocrine Unit
Jul 12, 2021
Cushings Disease Trial in Los Angeles (R-roscovitine)
Terminated
- Cushings Disease
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 1, 2021
Pituitary ACTH Hypersecretion, Acromegaly, Diabetes, Type 1 Trial in Moscow (Cholecalciferol 15000 UNT/ML Oral Solution)
Completed
- Pituitary ACTH Hypersecretion
- +3 more
- Cholecalciferol 15000 UNT/ML Oral Solution
-
Moscow, Russian FederationEndocrinology Research Centre, Moscow
Aug 10, 2022
Defining Genetic Basis for Development of Primary Pigmented
Completed
- Cushing's Syndrome
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 18, 2023
Adrenal Diseases- Laparoscopic vs. Robotic-assisted
Recruiting
- Adrenal Tumor
- +12 more
-
Olomouc, CzechiaUniversity hospital Olomouc
Sep 17, 2023
Iatrogenic Cushing's Disease Trial in Oxford (AZD4017 and prednisolone, Placebo Oral Tablet and prednisolone)
Completed
- Iatrogenic Cushing's Disease
- AZD4017 and prednisolone
- Placebo Oral Tablet and prednisolone
-
Oxford, United KingdomUniversity of Oxford
May 12, 2021
Discriminant Capacity and Thresholds of Salivary Cortisol in
Recruiting
- Cushing Disease
- Blood test
- +3 more
-
Nîmes, FranceCHU de Nimes
Oct 4, 2021
China Adrenal Disease Registry
Recruiting
- Cushing Syndrome
- +7 more
-
Shanghai, ChinaEndocrinology
Jan 28, 2022
Cushing's Disease Trial in Bron ([11C]-Methionine PET/MRI)
Completed
- Cushing's Disease
- [11C]-Methionine PET/MRI
-
Bron, FranceService de Médecine Nucléaire - Hospices Civils de Lyon
Nov 30, 2020
Cushing's Disease Trial in Worldwide (osilodrostat, osilodrostat Placebo)
Completed
- Cushing's Disease
- osilodrostat
- osilodrostat Placebo
-
Aurora, Colorado
- +35 more
Oct 20, 2021
Long-term Cardiovascular Risk in Cured Cushing's Patients
Terminated
- Cushing's Disease
-
Boston, MassachusettsNeuroendocrine Clinical Center
Aug 31, 2020